Publications by authors named "Brandon Shore"

Article Synopsis
  • The study investigates the effectiveness of oral (PO) versus intravenous (IV) antibiotics for patients with Crohn's disease (CD) who were hospitalized for intra-abdominal abscesses.
  • Results show that patients discharged on IV antibiotics had significantly lower rates of nonsurgical readmissions within one year compared to those on PO antibiotics (40% vs 77%).
  • No significant differences were found in the need for surgery or time until surgery between the two groups, indicating that while IV antibiotics may reduce readmissions, both methods ultimately have similar surgical outcomes.
View Article and Find Full Text PDF

The population of older patients with inflammatory bowel disease (IBD) is expected to continue to increase in the coming decades, which necessitates and improved understanding of the critical issues faced by patients in this population. Although restorative proctocolectomy with IPAA remains the surgical procedure of choice for the majority of patients with medically refractory ulcerative colitis (UC) and UC-related dysplasia, the evidence surrounding surgery for older patients UC remains sparse. In particular, comparisons of outcomes among older and younger patients undergoing IPAA and comparisons between older patients undergoing IPAA and those undergoing proctocolectomy with end ileostomy remain an understudied and important issue, as evidence in this area will be used to guide patient-centered surgical choices among older patients who require colectomy for UC.

View Article and Find Full Text PDF

Background: Recurrent or chronic antibiotic therapy is a therapeutic hallmark of chronic antibiotic-dependent pouchitis (CADP) or Crohn's-like disease of the pouch. Antibiotics alter the gut microbiome, which may increase the risk of Clostridioides difficile infection (CDI). The aim of this study was to determine the prevalence of CDI in patients with CADP and Crohn's-like disease of the pouch.

View Article and Find Full Text PDF

Goals: The goal of this study was to compare the relative safety of administering iron infusions on the same day as intravenous (IV) biological therapy to the administration of these treatments on different days in patients with inflammatory bowel disease (IBD).

Background: IV iron therapy is often required in patients with IBD. Many patients with IBD who receive IV iron therapy in the outpatient setting also receive biological infusion therapy for treatment of their IBD.

View Article and Find Full Text PDF

Colorectal cancer (CRC) is a common malignancy in the U.S. and worldwide.

View Article and Find Full Text PDF

Many safe and effective severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccinations dramatically reduce risks of coronavirus disease 2019 (COVID-19) complications and deaths. We aimed to describe cases of SARS-CoV-2 infection among patients with chronic liver disease (CLD) and liver transplant (LT) recipients with at least one prior COVID-19 vaccine dose. The SECURE-Liver and COVID-Hep international reporting registries were used to identify laboratory-confirmed COVID-19 in CLD and LT patients who received a COVID-19 vaccination.

View Article and Find Full Text PDF